| Lastest Insider Transactions Of Apogee Therapeutics, Inc. ( APGE ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| APGE | Apogee Therapeutics, Inc. | HENDERSON MICHAEL THOMAS | Chief Executive Officer | 2026-02-11 | Sell | 20,000 | 63.35 | 1,266,953 | 2026-02-13 20:00:15 |
| APGE | Apogee Therapeutics, Inc. | Dambkowski Carl | Chief Medical Officer | 2026-02-04 | Sell | 5,500 | 65.79 | 361,860 | 2026-02-04 20:02:30 |
| APGE | Apogee Therapeutics, Inc. | Dambkowski Carl | Chief Medical Officer | 2026-02-04 | Option Exercise | 4,125 | 22.86 | 94,298 | 2026-02-04 20:02:30 |
| APGE | Apogee Therapeutics, Inc. | Henderson Jane | Chief Financial Officer | 2026-02-02 | Sell | 2,000 | 65.81 | 131,630 | 2026-02-04 20:01:01 |
| APGE | Apogee Therapeutics, Inc. | Fairmount Funds Management LLC | Directior | 2026-01-22 | Sell | 1,750,000 | 76.30 | 133,525,000 | 2026-01-22 20:07:15 |
| APGE | Apogee Therapeutics, Inc. | HENDERSON MICHAEL THOMAS | Chief Executive Officer | 2026-01-14 | Sell | 20,000 | 81.11 | 1,622,159 | 2026-01-16 20:00:23 |
| APGE | Apogee Therapeutics, Inc. | Dambkowski Carl | Chief Medical Officer | 2026-01-07 | Sell | 18,700 | 77.84 | 1,455,613 | 2026-01-09 20:00:26 |
| APGE | Apogee Therapeutics, Inc. | Dambkowski Carl | Chief Medical Officer | 2026-01-07 | Option Exercise | 14,025 | 22.86 | 320,612 | 2026-01-09 20:00:26 |
| APGE | Apogee Therapeutics, Inc. | Henderson Jane | Chief Financial Officer | 2026-01-02 | Sell | 8,000 | 76.14 | 609,146 | 2026-01-06 20:00:42 |
| APGE | Apogee Therapeutics, Inc. | Henderson Jane | Chief Financial Officer | 2025-12-19 | Sell | 1,500 | 80.00 | 120,000 | 2025-12-23 20:00:22 |
| APGE | Apogee Therapeutics, Inc. | HENDERSON MICHAEL THOMAS | Chief Executive Officer | 2025-12-10 | Sell | 20,000 | 75.38 | 1,507,657 | 2025-12-12 20:00:11 |
| APGE | Apogee Therapeutics, Inc. | Dambkowski Carl | Chief Medical Officer | 2025-12-04 | Sell | 10,900 | 75.00 | 817,500 | 2025-12-05 20:03:48 |
| APGE | Apogee Therapeutics, Inc. | Henderson Jane | Chief Financial Officer | 2025-12-04 | Sell | 1,500 | 75.00 | 112,500 | 2025-12-05 20:02:10 |
| APGE | Apogee Therapeutics, Inc. | HENDERSON MICHAEL THOMAS | Chief Executive Officer | 2025-12-04 | Sell | 40,000 | 75.01 | 3,000,400 | 2025-12-05 20:00:16 |
| APGE | Apogee Therapeutics, Inc. | Henderson Jane | Chief Financial Officer | 2025-11-25 | Sell | 1,500 | 70.00 | 105,000 | 2025-11-28 20:00:22 |
| APGE | Apogee Therapeutics, Inc. | Henderson Jane | Chief Financial Officer | 2025-11-14 | Sell | 2,000 | 65.00 | 130,000 | 2025-11-14 20:00:20 |
| APGE | Apogee Therapeutics, Inc. | Henderson Jane | Chief Financial Officer | 2025-11-11 | Sell | 1,000 | 60.00 | 60,000 | 2025-11-13 20:37:12 |
| APGE | Apogee Therapeutics, Inc. | HENDERSON MICHAEL THOMAS | Chief Executive Officer | 2025-11-13 | Sell | 20,000 | 63.01 | 1,260,236 | 2025-11-13 20:24:15 |
| APGE | Apogee Therapeutics, Inc. | Dambkowski Carl | Chief Medical Officer | 2025-11-05 | Sell | 10,785 | 55.07 | 593,903 | 2025-11-07 20:00:14 |
| APGE | Apogee Therapeutics, Inc. | Dambkowski Carl | Chief Medical Officer | 2025-11-05 | Option Exercise | 8,060 | 22.86 | 184,252 | 2025-11-07 20:00:14 |
| APGE | Apogee Therapeutics, Inc. | Dambkowski Carl | Chief Medical Officer | 2025-10-01 | Sell | 5,110 | 39.80 | 203,378 | 2025-10-03 20:00:21 |
| APGE | Apogee Therapeutics, Inc. | Dambkowski Carl | Chief Medical Officer | 2025-10-01 | Option Exercise | 2,385 | 22.86 | 54,521 | 2025-10-03 20:00:21 |
| APGE | Apogee Therapeutics, Inc. | Dambkowski Carl | Chief Medical Officer | 2025-09-03 | Sell | 2,725 | 37.87 | 103,198 | 2025-09-05 20:00:11 |
| APGE | Apogee Therapeutics, Inc. | Dambkowski Carl | Chief Medical Officer | 2025-08-06 | Sell | 2,725 | 37.78 | 102,951 | 2025-08-08 20:00:15 |
| APGE | Apogee Therapeutics, Inc. | Dambkowski Carl | Chief Medical Officer | 2025-07-02 | Sell | 10,090 | 45.09 | 454,954 | 2025-07-03 20:00:07 |
| APGE | Apogee Therapeutics, Inc. | Dambkowski Carl | Chief Medical Officer | 2025-07-02 | Option Exercise | 7,365 | 22.86 | 168,364 | 2025-07-03 20:00:07 |
| APGE | Apogee Therapeutics, Inc. | Dambkowski Carl | Chief Medical Officer | 2025-06-04 | Sell | 2,725 | 36.96 | 100,716 | 2025-06-06 20:01:21 |
| APGE | Apogee Therapeutics, Inc. | Dambkowski Carl | Chief Medical Officer | 2025-05-07 | Sell | 2,725 | 35.75 | 97,419 | 2025-05-09 20:01:12 |
| APGE | Apogee Therapeutics, Inc. | Dambkowski Carl | Chief Medical Officer | 2025-04-02 | Sell | 3,860 | 36.22 | 139,801 | 2025-04-04 20:01:18 |
| APGE | Apogee Therapeutics, Inc. | Dambkowski Carl | Chief Medical Officer | 2025-03-05 | Sell | 1,590 | 30.48 | 48,463 | 2025-03-07 20:02:04 |
| APGE | Apogee Therapeutics, Inc. | HENDERSON MICHAEL THOMAS | Chief Executive Officer | 2025-03-05 | Sell | 10,000 | 30.15 | 301,511 | 2025-03-07 20:01:16 |
| APGE | Apogee Therapeutics, Inc. | Dambkowski Carl | Chief Medical Officer | 2025-02-05 | Sell | 3,520 | 40.69 | 143,229 | 2025-02-07 20:02:15 |
| APGE | Apogee Therapeutics, Inc. | Dambkowski Carl | Chief Medical Officer | 2025-02-05 | Option Exercise | 795 | 22.86 | 18,174 | 2025-02-07 20:02:15 |
| APGE | Apogee Therapeutics, Inc. | HENDERSON MICHAEL THOMAS | Chief Executive Officer | 2025-02-05 | Sell | 15,000 | 40.58 | 608,700 | 2025-02-07 20:01:10 |
| APGE | Apogee Therapeutics, Inc. | HENDERSON MICHAEL THOMAS | Chief Executive Officer | 2025-01-31 | Option Exercise | 8,500 | 22.86 | 194,310 | 2025-01-31 20:00:12 |
| APGE | Apogee Therapeutics, Inc. | HENDERSON MICHAEL THOMAS | Chief Executive Officer | 2025-01-08 | Sell | 15,000 | 48.85 | 732,693 | 2025-01-10 20:00:07 |
| APGE | Apogee Therapeutics, Inc. | Dambkowski Carl | Chief Medical Officer | 2025-01-02 | Sell | 4,085 | 46.94 | 191,740 | 2025-01-03 20:00:10 |
| APGE | Apogee Therapeutics, Inc. | Dambkowski Carl | Chief Medical Officer | 2025-01-02 | Option Exercise | 1,360 | 22.86 | 31,090 | 2025-01-03 20:00:10 |
| APGE | Apogee Therapeutics, Inc. | McKenna Mark C. | Directior | 2024-12-12 | Buy | 20,000 | 49.54 | 990,775 | 2024-12-16 06:00:10 |
| APGE | Apogee Therapeutics, Inc. | Dambkowski Carl | Chief Medical Officer | 2024-12-11 | Sell | 4,540 | 48.76 | 221,363 | 2024-12-13 20:01:11 |
| APGE | Apogee Therapeutics, Inc. | Dambkowski Carl | Chief Medical Officer | 2024-12-11 | Option Exercise | 1,815 | 22.86 | 41,491 | 2024-12-13 20:01:11 |
| APGE | Apogee Therapeutics, Inc. | Dambkowski Carl | Chief Medical Officer | 2024-12-04 | Sell | 6,665 | 46.07 | 307,057 | 2024-12-06 20:02:06 |
| APGE | Apogee Therapeutics, Inc. | HENDERSON MICHAEL THOMAS | Chief Executive Officer | 2024-12-04 | Sell | 15,000 | 46.58 | 698,654 | 2024-12-06 20:01:08 |
| APGE | Apogee Therapeutics, Inc. | Dambkowski Carl | Chief Medical Officer | 2024-11-06 | Sell | 6,665 | 59.12 | 394,041 | 2024-11-08 20:02:19 |
| APGE | Apogee Therapeutics, Inc. | HENDERSON MICHAEL THOMAS | Chief Executive Officer | 2024-11-06 | Sell | 15,000 | 59.22 | 888,320 | 2024-11-08 20:01:14 |
| APGE | Apogee Therapeutics, Inc. | Dambkowski Carl | Chief Medical Officer | 2024-10-02 | Sell | 6,665 | 56.26 | 374,954 | 2024-10-04 20:02:03 |
| APGE | Apogee Therapeutics, Inc. | HENDERSON MICHAEL THOMAS | Chief Executive Officer | 2024-10-02 | Sell | 40,000 | 56.23 | 2,249,307 | 2024-10-04 20:01:09 |
| APGE | Apogee Therapeutics, Inc. | Henderson Jane | Chief Financial Officer | 2024-08-23 | Sell | 6,000 | 48.26 | 289,560 | 2024-08-23 20:05:04 |
| APGE | Apogee Therapeutics, Inc. | Henderson Jane | Chief Financial Officer | 2024-08-23 | Sell | 6,000 | 48.26 | 289,560 | 2024-08-23 20:05:04 |
| APGE | Apogee Therapeutics, Inc. | Dambkowski Carl | Chief Medical Officer | 2024-08-07 | Sell | 7,335 | 40.67 | 298,336 | 2024-08-09 20:05:47 |
| APGE | Apogee Therapeutics, Inc. | Dambkowski Carl | Chief Medical Officer | 2024-08-07 | Sell | 7,335 | 40.67 | 298,336 | 2024-08-09 20:05:47 |
| APGE | Apogee Therapeutics, Inc. | HENDERSON MICHAEL THOMAS | Chief Executive Officer | 2024-08-07 | Sell | 40,000 | 40.62 | 1,624,764 | 2024-08-09 20:05:12 |
| APGE | Apogee Therapeutics, Inc. | Dambkowski Carl | Chief Medical Officer | 2024-08-07 | Sell | 7,335 | 40.67 | 298,336 | 2024-08-09 20:01:54 |
| APGE | Apogee Therapeutics, Inc. | Dambkowski Carl | Chief Medical Officer | 2024-08-07 | Sell | 7,335 | 40.67 | 298,336 | 2024-08-09 20:01:54 |
| APGE | Apogee Therapeutics, Inc. | HENDERSON MICHAEL THOMAS | Chief Executive Officer | 2024-07-05 | Sell | 15,000 | 37.26 | 558,900 | 2024-07-05 20:01:58 |
| APGE | Apogee Therapeutics, Inc. | Dambkowski Carl | Chief Medical Officer | 2024-07-03 | Sell | 5,995 | 37.60 | 225,418 | 2024-07-05 20:01:11 |
| APGE | Apogee Therapeutics, Inc. | Shah Nimish P | Directior | 2023-07-13 | Buy | 1,750,000 | 17.00 | 29,750,000 | 2023-07-17 20:00:49 |
| APGE | Apogee Therapeutics, Inc. | Fairmount Funds Management LLC | Directior | 2023-07-13 | Buy | 2,941,176 | 17.00 | 49,999,992 | 2023-07-17 20:00:23 |
